非药物糖尿病预防计划的交付方式的有效性:系统性审查和组件网络元分析
Ellesha A Smith1, Stephanie J Hubbard1, Suzanne C Freeman1
1Department of Population Health Sciences, University of Leicester, UK.
Diabetes & metabolic syndrome
|October 17, 2024
概括
亲自提供生活方式干预措施是预防2型糖尿病最有效的方法. 未来的努力应加强数字化计划,并确保高风险人群获得公平的机会.
科学领域:
- 公共卫生和预防医学
- 代谢疾病和内分泌学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 2型糖尿病预防计划是有效的,但由于成本和强度,在日常实施方面面临挑战.
- 交付方式显著影响糖尿病预防生活方式干预措施的有效性.
- 确定干预交付的关键组成部分对于务实实施和保持有效性至关重要.
研究的目的:
- 系统地审查和进行非药物糖尿病预防计划的组件网络元分析.
- 评估哪些交付方式组件与高风险个体的2型糖尿病发病率降低有关.
- 为未来糖尿病预防干预措施的实施策略提供信息.
主要方法:
- 系统审查和组件网络转化研究的元分析,比较生活方式干预措施.
- 在 MEDLINE,科克伦图书馆,Opengrey 和 clinicaltrials.gov 搜索到 2022 年 11 月 17 日.
- 包括至少12个月的随访研究;由两名研究人员提取的数据;使用的随机效应模型.
主要成果:
- 包括50项符合条件的研究,共有29286名参与者 (72%是RCT).
- 在人 (个人交付) 的干预措施显示,2型糖尿病发病率更大降低 (HR:0.66).
- 在人 (以小组为基础) 的干预导致体重 (MD:-1.53公斤) 和HbA1c (MD: -0.74 mmol/mol) 显著减少.
结论:
- 在2型糖尿病的预防方面,亲自交付模式显示出最高的有效性.
- 未来的研究应该优先提高数字糖尿病预防计划的有效性.
- 确保为目标人群提供有效干预措施的优先交付对于减少健康不平等至关重要.
相关概念视频
01:15Diabetes: Management and Pharmacotherapy
238
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
238
01:22Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
01:26Levels of Health Promotion and Illness Prevention
12.5K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
In primary prevention, actions taken before disease onset prevent the disease from...
12.5K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
178
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
178
01:22Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
01:26Peripheral Artery Disease IV: Nursing Management
3
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
3